Plunkett Research Online: ZIOPHARM Oncology Inc

ZIOPHARM ONCOLOGY INC (ZIOP:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

ZIOPHARM Oncology, Inc. is a biopharmaceutical focused on discovering, acquiring, developing and commercializing next-generation immunotherapy platforms that leverage cell- and gene-based therapies to treat patients with cancer. The company is developing two immuno-oncology platform technologies th.....



ZIOPHARM Oncology Inc
Ticker: ZIOP
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 617-259-1970
Fax: 617-241-2855
Address: One First Avenue, Parris Building 34
Navy Yard Plaza
Boston, MA 02129 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Biopharmaceutical Development
ContactsDescription
Laurence CooperCEO/Director
Kevin LafondCFO/Chief Accounting Officer/Senior VP, Divisional/Treasurer
See More
ZIOPHARM Oncology, Inc. is a biopharmaceutical focused on discovering, acquiring, developing and commercializing next-generation immunotherapy platforms that leverage cell- and gene-based therapies to treat patients with cancer. The company is developing two immuno-oncology platform technologies th.....See More See More

Auditor: RSM US LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201820172016201520142013
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
Sleeping Beauty
Controlled IL-12
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: